Find the gap

The spread of infectious disease disproportionately affects those who live in communities where many people are uninsured, underserved or experiencing poverty.  
Care gaps in the healthcare market and an array of clinical and social determinants of health barriers make it difficult for people to treat, manage and prevent the spread of disease.

Close the gap

Health equity

Disease burden

Comorbidities

Disease progression

Powered by Ceros

Close the gap

Find the gap

Use comprehensive patient journey data to spot lags between healthcare visits and prescriptions filled. Then get to know the risks, signs and behaviors that lead patients to discontinue treatment so you can prevent severe events.

Diseases that progress rapidly tend to get better medical care than those that progress slowly. Patient data shows us that when patients start to feel better, their adherence to a prescribed therapy drops, putting them at a much higher risk for emergency events, hospitalization or aggressive treatments as their disease progresses.

Close the gap

Find the gap

Repackage respiratory medication in easy-opening pill bottles to prevent people from skipping, switching or stopping therapy.

Senior citizens with respiratory disease often develop arthritis. As a result, many individuals may find it difficult to open the standard child-protected pill bottle containing their 
prescribed medication.

Close the gap

Find the gap

Speak to needle-averse patients about their prescribed treatment plans to help them overcome their fears or find other treatment options that are more likely to work for them.

In communities around the world, a long-held fear of needles keeps many people from following prescribed treatment plans for intravenous drugs.

Close the gap

Find the gap

Use population data and patient health insights to see where to raise the standard of care in infectious disease hot spots. By collaborating with local healthcare partners to drive effective care strategies, get patients on the right treatments and address healthcare disparities, pharma companies can raise awareness, enhance patient support programs and build trust in their ability to deliver quality care.

The spread of infectious disease disproportionately affects those who live in communities where many people are uninsured, underserved or experiencing poverty.  
Care gaps in the healthcare market and an array of clinical and social determinants of health barriers make it difficult for people to treat, manage and prevent the spread of disease.

Disease progression

Comorbidities

Disease burden

Health equity